Lupin Strengthens Portfolio with Acquisition of Diabetes Brands Ondero and Ondero Met from Boehringer Ingelheim August 22, 2023 Lupin, an Indian pharmaceutical company, has recently disclosed its acquisition of the diabetes brands Ondero and Ondero Met from Boehringer Ingelheim International GmbH.